MONTIRONI, Rodolfo
 Distribuzione geografica
Continente #
NA - Nord America 51.760
EU - Europa 21.608
AS - Asia 20.723
SA - Sud America 5.651
AF - Africa 941
Continente sconosciuto - Info sul continente non disponibili 764
OC - Oceania 23
AN - Antartide 1
Totale 101.471
Nazione #
US - Stati Uniti d'America 50.804
SG - Singapore 6.534
BR - Brasile 4.464
VN - Vietnam 4.318
RU - Federazione Russa 3.947
UA - Ucraina 3.884
CN - Cina 2.558
IT - Italia 2.430
IE - Irlanda 2.241
HK - Hong Kong 2.237
DE - Germania 2.074
TR - Turchia 2.006
SE - Svezia 1.813
DK - Danimarca 1.440
FR - Francia 1.365
FI - Finlandia 979
GB - Regno Unito 813
KR - Corea 811
IN - India 460
BD - Bangladesh 429
AR - Argentina 411
CA - Canada 400
CI - Costa d'Avorio 326
MX - Messico 283
ID - Indonesia 215
EC - Ecuador 203
IQ - Iraq 193
ZA - Sudafrica 192
CO - Colombia 173
JP - Giappone 125
MA - Marocco 117
NL - Olanda 113
PK - Pakistan 110
VE - Venezuela 104
PL - Polonia 97
UZ - Uzbekistan 94
PH - Filippine 88
PY - Paraguay 85
ES - Italia 82
CL - Cile 72
SA - Arabia Saudita 66
BE - Belgio 59
EG - Egitto 57
EU - Europa 52
PE - Perù 52
TH - Thailandia 52
TN - Tunisia 52
JO - Giordania 48
UY - Uruguay 47
CR - Costa Rica 42
JM - Giamaica 41
MY - Malesia 41
AT - Austria 39
HN - Honduras 38
KE - Kenya 38
DZ - Algeria 37
NP - Nepal 32
AE - Emirati Arabi Uniti 31
BO - Bolivia 31
KZ - Kazakistan 29
AZ - Azerbaigian 28
RO - Romania 28
EE - Estonia 25
LB - Libano 25
DO - Repubblica Dominicana 24
ET - Etiopia 23
OM - Oman 23
IL - Israele 22
TW - Taiwan 21
AL - Albania 20
GT - Guatemala 20
KG - Kirghizistan 20
PA - Panama 19
TT - Trinidad e Tobago 19
AU - Australia 18
BH - Bahrain 18
PS - Palestinian Territory 17
SV - El Salvador 16
BY - Bielorussia 14
CH - Svizzera 14
GR - Grecia 14
NG - Nigeria 14
NI - Nicaragua 14
RS - Serbia 14
SN - Senegal 14
AO - Angola 12
PR - Porto Rico 12
AM - Armenia 11
BG - Bulgaria 11
CZ - Repubblica Ceca 11
LT - Lituania 11
PT - Portogallo 11
BB - Barbados 9
HU - Ungheria 9
KW - Kuwait 9
LV - Lettonia 9
LY - Libia 9
MD - Moldavia 9
SK - Slovacchia (Repubblica Slovacca) 8
SY - Repubblica araba siriana 8
Totale 100.607
Città #
Ashburn 8.171
Singapore 4.046
Jacksonville 3.951
Chandler 3.301
Fairfield 3.242
Dallas 2.333
Dublin 2.235
Hong Kong 2.171
Boardman 2.150
Council Bluffs 1.894
Des Moines 1.842
Wilmington 1.781
San Jose 1.622
Woodbridge 1.434
Ho Chi Minh City 1.417
Seattle 1.288
Houston 1.281
New York 1.093
Cambridge 1.007
Hanoi 971
The Dalles 946
Princeton 909
Lawrence 908
San Mateo 892
Lauterbourg 812
Beijing 614
Moscow 604
Ann Arbor 600
Milan 542
Hefei 466
Los Angeles 458
San Diego 431
São Paulo 425
Centro 418
Abidjan 326
Santa Clara 256
Chicago 224
Da Nang 220
Buffalo 204
Munich 202
Haiphong 191
Helsinki 184
London 180
Rio de Janeiro 143
Orem 136
Pune 133
Miano 129
Shanghai 123
Phoenix 122
Mexico City 111
Washington 104
Tokyo 101
Norwalk 96
Atlanta 95
Guangzhou 91
Brooklyn 88
Tashkent 87
Belo Horizonte 86
Wuhan 86
Columbus 85
Warsaw 85
Montreal 81
Rome 81
Johannesburg 79
Turku 79
Curitiba 78
Guayaquil 78
Brasília 76
Redmond 75
Biên Hòa 74
Denver 72
Izmir 72
Porto Alegre 71
Frankfurt am Main 69
Toronto 69
Baghdad 67
Falls Church 62
Chennai 59
San Francisco 59
Hải Dương 58
Salt Lake City 57
Turin 57
Quito 56
Vancouver 55
Salvador 54
Can Tho 53
Brussels 52
Dhaka 51
Campinas 49
Marche 48
Boston 47
Kilburn 44
Thái Bình 44
Thái Nguyên 44
Amman 43
Elk Grove Village 43
Jakarta 43
Cape Town 41
Manchester 41
Santiago 40
Totale 62.464
Nome #
Urethral caruncle: clinicopathologic features of 41 cases 282
Metabolic phenotype of bladder cancer 271
Variation in reporting of cancer extent and benign histology in prostate biopsies among European pathologists. 252
Intratubular germ cell neoplasia of unclassified type 247
Lymphoepithelioma-like carcinoma of the urinary bladder: a clinicopathologic study of 13 cases. 240
Mitogen-activated protein kinases and apoptosis in PIN. 239
Handling and reporting of transurethral resection specimens of the bladder in Europe: a web-based survey by the European Network of Uropathology (ENUP). 235
Urothelial carcinoma with an inverted growth pattern can be distinguished from inverted papilloma by fluorescence in situ hybridization, immunohistochemistry, and morphologic analysis 232
Morphometric index of adult renal cell carcinoma. Comparison with the Fuhrman grading system. 224
Prostatic Intraepithelial Neoplasia - Development of A Bayesian Belief Network For Diagnosis and Grading. 216
Immunotherapy in genitourinary cancers: Where are we going? 214
Sequential or Concomitant Inhibition of Cyclin-Dependent Kinase 4/6 Before mTOR Pathway in Hormone-Positive HER2 Negative Breast Cancer: Biological Insights and Clinical Implications 210
Designing novel immunocombinations in metastatic renal cell carcinoma 207
OCT4: biological functions and clinical applications as a marker of germ cell neoplasia 204
Bone metastases in patients with metastatic renal cell carcinoma: Are they always associated with poor prognosis? 204
Activity and expression of nitric oxide synthase in rat bladder after sacral neuromodulation 203
Transcontinental communication and quantitative digital histopathology via the Internet; with special reference to prostate neoplasia 203
Predicting future cancer burden in the United States by artificial neural networks 203
Angiogenesis genotyping and clinical outcome during regorafenib treatment in metastatic colorectal cancer patients 198
BAP1, PBRM1 and SETD2 in clear-cell renal cell carcinoma: Molecular diagnostics and possible targets for personalized therapies 198
2004 WHO classification of the renal tumors of the adults. 197
A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer. 193
Clinical performance and utility of a NNMT-based urine test for bladder cancer 191
Androgen Receptor Signaling Pathway in Prostate Cancer: From Genetics to Clinical Applications 189
Computational analysis of the mutations in BAP1, PBRM1 and SETD2 genes reveals the impaired molecular processes in Renal Cell Carcinoma 188
[International Society of Urological Pathology (ISUP) Consensus Conference on handling and staging of radical prostatectomy specimens]. 186
Standardized mitotic counts in breast cancer evaluation of the method 185
D2-40 immunoreactivity in penile squamous cell carcinoma: a marker of aggressiveness 184
Biological issues with cabozantinib in bone metastatic renal cell carcinoma and castration-resistant prostate cancer 183
Ciliary neurotrophic factor (CNTF) and its receptor (CNTFRα) signal through MAPK/ERK pathway in human prostate tissues: a morphological and biomolecular study 182
The Role of Artificial Intelligence in the Diagnosis and Prognosis of Renal Cell Tumors 180
"Pathological" reflection on European urology: extended, saturation, and systematic prostate biopsies. 179
Cognitive zonal fusion biopsy of the prostate: Original technique between target and saturation. 178
Re: Umberto Leone Roberti Maggiore, Simone Ferrero, Massimo Candiani, et al. Bladder Endometriosis: A Systematic Review of Pathogenesis, Diagnosis, Treatment, Impact on Fertility, and Risk of Malignant Transformation. Eur Urol 2017;71:790–807 177
Prognostic value of CD44 expression in penile squamous cell carcinoma: a pilot study. 177
Biomarkers of aggressiveness in genitourinary tumors with emphasis on kidney, bladder, and prostate cancer 177
Exploring the Spectrum of Kidney Ciliopathies 175
Chromosomal Abnormalities in Macroscopically Normal Urothelium in Patiens with Bladder pT1 and pT2a Urothelial Carcinoma: a Fluorescence in situ hybridisation Study and Correlation with Histologic Features. 174
Secondary neoplasms of the urinary system and male genital organs. 173
Role of DNA analysis and mutation of P53 gene in small dimension renal carcinomas. Biological significance and long-term follow-up 172
HER2 expression and gene amplification in pT2a Gleason score 6 prostate cancer incidentally detected in cystoprostatectomies: comparison with clinically detected andreogen-dependent and androgen-independent cancer. 170
[Interstitial cystitis: minimal diagnostic criteria]. 170
[Gene p53 mutation and prognosis in bladder tumors]. 168
Activity of chemokines in prostate and renal tumors and their potential role as future therapeutic targets 168
[Thin glomerular basement membrane disease]. 167
Adjuvant and neoadjuvant approaches for urothelial cancer: Updated indications and controversies 167
Oligometastases in Genitourinary Tumors: Recent Insights and Future Molecular Diagnostic Approach 166
Epithelial to Mesenchymal Transition in Renal Cell Carcinoma: Implications for Cancer Therapy 165
Germline and somatic mutations in prostate cancer: Focus on defective DNA repair, PARP inhibitors and immunotherapy 165
Green fluorescent protein as indicator of non-viral transient transfection efficiency in endometrial and testicular biopsies 164
Nuclear changes in the normal-looking columnar epithelium adjacent to and distant from prostatic intraepithelial neoplasia and prostate cancer. Morphometric analysis in whole-mount sections. 164
Primary B-cell lymphoblastic lymphoma of the testis 164
An update on investigational therapies that target STAT3 for the treatment of cancer 164
2004 World Health Organization Classification of the Noninvasive Urothelial Neoplasms: Inherent Problems and Clinical Reflections 163
Genitourinary tumors: Update on molecular biomarkers for diagnosis, prognosis and prediction of response to therapy 163
Artificial Neural Networks as a Way to Predict Future Kidney Cancer Incidence in the United States 163
The Role of Focal Therapy in the Management of Localised Prostate Cancer: A Systematic Review. 162
[Gleason's grading of prostatic cancer: a current perspective]. 162
Microbiome and cancers, with focus on genitourinary tumors 162
alpha-methylacyl-CoA racemase (P504S)/34 beta E12/p63 triple cocktail stain in prostatic adenocarcinoma after hormonal therapy 161
A randomized phase IIb presurgical study of finasteride vs. low-dose flutamide vs. placebo in men with prostate cancer. Efficacy monitored by karyometry 161
[Adrenal metastasis: clinical and pathological aspects]. 160
Perivascular epithelioid cell tumor (PEC-ome) of the prostate: ultrasound feature in case report 160
Contemporary best practice in the management of urothelial carcinomas of the renal pelvis and ureter 160
Morphologic, Molecular and Clinical Features of Aggressive Variant Prostate Cancer 160
PD-1 blockade therapy in renal cell carcinoma: current studies and future promises 159
Tumor VEGF expression correlates with tumor stage and identifies prognostically different groups in clear cell renal cell carcinoma patients 159
Atypical foci, suspicious but not diagnostic of malignancy in prostate needle biopsies (also referred to as "atypical small acinar proliferation suspicious for but not diagnostic of malignancy") 158
[Prostate biopsy: characteristics of the histological sample]. 158
Metabolic Alterations in Renal and Prostate Cancer 157
Do DNA methylation and histone acetylation play a role in clear cell renal carcinoma? Analysis of radical nephrectomy specimens in a long-term follow-up. 156
Morphologic Variants of Epithelial and Neuroendocrine Tumors of the Prostate. The Pathologist's Point of View 156
Molecular characterization of testicular germ cell tumors using tissue microdissection 155
Immunohistochemical expression of somatostatin receptor subtypes in prostate tissue from cystoprostatectomies with incidental prostate cancer. 154
Active surveillance for low-risk prostate cancer. 154
Adipose cannabinoid CB1 receptor expression and adiponectin correlate with microvascular damage in human kidney 153
Succinate dehydrogenase-deficient renal cell carcinoma: Detailed characterization of 11 tumors defining a unique subtype of renal cell carcinoma 152
The role of obesity in renal cell carcinoma patients: Clinical-pathological implications 152
Bone targeting agents in patients with metastatic prostate cancer: State of the art 152
Added Clinical Value of Whole-mount Histopathology of Radical Prostatectomy Specimens: A Collaborative Review 152
AT-rich interactive domain 1A (ARID1A) cannot be considered a morphological marker for prostate cancer progression: A pilot study 152
Effect of complete androgen blockade on pathologic stage and resection margin status of prostate cancer: Progress pathology report of the Italian PROSIT study 151
Prognostic role of tumor necrosis, microvessel density, vascular endothelial growth factor and hypoxia inducible factor-1 alpha in patients with clear cell renal carcinoma after radical nephrectomy in a long term follow-up 150
Improving inter-observer agreement and certainty level in diagnosing and grading papillary urothelial neoplasms: usefulness of a Bayesian belief network. 150
2009 update on the classification of renal epithelial tumors in adults 150
[The kidney in rheumatoid arthritis]. 150
Resistance to systemic agents in renal cell carcinoma predict and overcome genomic strategies adopted by tumor 150
Adjuvant therapy in renal cell carcinoma: Is it the right strategy to inhibit VEGF? 150
Basal cell hyperplasia and basal cell carcinoma of the prostate: a comprehensive review and discussion of a case with c-erbB-2 expression. 149
[Nephrotic proteinuria with type 2 diabetes mellitus and autoimmune thyroiditis]. 149
Narrative review of prostate cancer grading systems: Will the Gleason scores be replaced by the grade groups? 149
Diagnostic Criteria for Ductal Adenocarcinoma of the Prostate.Interobserver Variability among 20 Expert Uropathologists. 149
[Quantitative microscopy in histopathology]. 147
2005 update on pathology of prostate biopsies with cancer 147
International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 2: T2 substaging and prostate cancer volume 147
Is There a Role for Immunotherapy in Prostate Cancer? 147
An evaluation of current prostate cancer diagnostic approaches with emphasis on liquid biopsies and prostate cancer 146
MRI and pathological examination of post-mortem brains: the problem of white matter high signal areas. 145
A low grade PIN-like neoplasm of the transition zone immunohistochemically negative for basal cell markers: a possible example of low grade adenocarcinoma with stratified epithelium. 145
Adult primary paratesticular mesenchymal tumors with emphasis on a case presentation and discussion of spermatic cord leiomyosarcoma. 145
Totale 17.516
Categoria #
all - tutte 487.595
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 487.595


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.336 0 0 0 320 93 550 203 433 471 538 384 1.344
2022/202311.106 1.117 781 605 970 808 2.574 11 656 2.831 51 421 281
2023/20246.103 1.234 164 343 996 1.048 1.157 112 111 20 94 56 768
2024/202512.595 1.094 1.127 630 341 398 468 1.047 556 3.732 937 957 1.308
2025/202632.743 1.469 2.441 2.552 3.702 2.669 2.157 5.810 3.643 3.196 2.815 655 1.634
2026/20276.991 1.564 1.782 1.912 1.733 0 0 0 0 0 0 0 0
Totale 101.471